Pulse Biosciences, Inc. (PLSE) — 10-Q Filings
All 10-Q filings from Pulse Biosciences, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Pulse Biosciences' Losses Widen Amid R&D Surge, Initial Revenue
— Nov 5, 2025 Risk: high
Pulse Biosciences, Inc. reported product revenue of $86,000 for both the three and nine months ended September 30, 2025, a significant increase from zero revenu -
Pulse Biosciences Raises Capital Amidst Continued Losses
— Aug 12, 2025 Risk: high
PULSE BIOSCIENCES, INC. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for -
Pulse Biosciences Q1 2025: Revenue Flat, Expenses High
— May 8, 2025 Risk: high
Pulse Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported $0.001 in revenue for the first quarter of 2025, with total as -
Pulse Biosciences Q3 2024: Net Loss and Operating Expenses Detailed
— Oct 30, 2024 Risk: medium
Pulse Biosciences, Inc. filed its Q3 2024 10-Q report on October 30, 2024, detailing its financial performance for the period ending September 30, 2024. The com -
Pulse Biosciences Q2 2024: Revenue Flat, Expenses Rise
— Aug 19, 2024 Risk: medium
Pulse Biosciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported minimal revenue, with total revenues for the six months ended J -
Pulse Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: low
Pulse Biosciences, Inc. (PLSE) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Pulse Biosciences, Inc. reported financial results for the quarter e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX